Decreased mRNA and protein expression of peroxiredoxin (PRDX6) in the COPD lung

R. J. Davis, M. A. J. Horn, B. Thome-Kromer, R. A. Coleman, K. L. Clark (Royston, United Kingdom)

Source: Annual Congress 2004 - A translational approach to mechanisms of lung disease
Session: A translational approach to mechanisms of lung disease
Session type: Thematic Poster Session
Number: 2035
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. J. Davis, M. A. J. Horn, B. Thome-Kromer, R. A. Coleman, K. L. Clark (Royston, United Kingdom). Decreased mRNA and protein expression of peroxiredoxin (PRDX6) in the COPD lung. Eur Respir J 2004; 24: Suppl. 48, 2035

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nrf2-Dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010


Expression and cell specific localization of glutathione-S-transferase omega in healthy human lung and COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 339s
Year: 2006

Reduced bronchial epithelial Smad7 protein expression in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 3s
Year: 2005

Glutathione S-transferase copy number variation alters lung gene expression
Source: Eur Respir J 2011; 37: 15-28
Year: 2011



Downregulation of the pro-apototic gene, BNIPL, in bronchial biopsies from COPD patients
Source: ERS Lung Science Conference 2017
Year: 2017

Cell-specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 76s
Year: 2001

Distribution and mRNA expression of tenascin-C in developing human lung
Source: Eur Respir J 2001; 18: Suppl. 33, 244s
Year: 2001

RNA-binding protein HuR inhibits the expression of sirtuin-1 in patients with COPD
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017



Reduced expression of CD44 on lung macrophages from patients with COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010


The effect of MRP1 variants and the intensity of MRP1 protein expression in bronchial biopsies on lung function decline in COPD
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010

Apoptosis regulatory protein (p53, Bcl-2, survivin) expression in lung cancer-preliminary study
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008


Homeobox-genes (HOX) in human lung - altered expression in lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 477s
Year: 2001

Expression of the Bcl-2 binding protein beclin 1 in human idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011


Localization of cytoglobin, a novel protein, in lung tissues
Source: Eur Respir J 2005; 26: Suppl. 49, 551s
Year: 2005

Expression of peroxiredoxin I, III and thioredoxin in human lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 102s
Year: 2005

Activation of NRF2 is responsible for the overexpression of peroxiredoxin and sulphiredoxin in human lung cancer
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009

Increased expression of MMP-2 in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 361s
Year: 2005

Characterisation of eppin function: expression and activity in the lung
Source: Eur Respir J, 50 (1) 1601937; 10.1183/13993003.01937-2016
Year: 2017



Decreased expression of FENDRR, a lung mesenchymal long non-coding RNA, regulates fibroblast phenotypes in IPF through NOX4.
Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Year: 2017



Genes affecting mRNA stability and metalloproteinase inhibitor RECK are down-regulated in patients with COPD
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013